Otolaryngology · Aiea, HI
NPI
1205852217
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
98-1079 Moanalua Rd Ste 660
Aiea, HI, 96701
Phone (808) 622-2626
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,115 services
Medicare patients, 2024
372
Average age 77
Drug cost, 2024
$33K
937 prescriptions
Company payments, 2025
$463
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Regala was code 99213 (office e&m - established), 491 times for 292 patients. In total Christopher Regala billed 1,115 services in 19 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 491 | 292 | $64.22 | $32K |
| 69210 Other Organ Systems | Office | 226 | 172 | $32.16 | $7,268 |
| 99203 Office E&M - New | Office | 154 | 154 | $75.91 | $12K |
| 31231 Nasal/Sinus Endoscopy | Office | 150 | 132 | $142.54 | $21K |
| 92504 E&M - Miscellaneous | Office | 31 | 23 | $19.99 | $620 |
| 92567 Test - Miscellaneous | Office | 20 | 19 | $11.88 | $238 |
| 99212 Office E&M - Established | Office | 12 | 12 | $30.04 | $360 |
By year: 2022 $80K for 1,116 services; 2023 $77K for 1,055 services; 2024 $77K for 1,115 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Regala prescribed most often to Medicare patients was Fluticasone Propionate, with 282 prescriptions and refills. In total Christopher Regala wrote 937 Medicare prescriptions that cost $33K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 282 | 590 | 108 | $4,281 |
| Famotidine Generic | 121 | 256 | 55 | $3,114 |
| Flunisolide Generic | 74 | 123 | 33 | $3,731 |
| Omeprazole Generic | 50 | 110 | 16 | $685 |
| Mometasone Furoate Generic | 48 | 101 | 12 | $9,526 |
| Ipratropium Bromide Generic | 34 | 64 | 15 | $1,001 |
| Azelastine Hcl Generic | 32 | 61 | 17 | $1,372 |
| Mupirocin Generic | 31 | 31 | 24 | $213 |
| Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort | 30 | 30 | 23 | $1,348 |
| Montelukast Sodium Generic | 19 | 53 | Under 11 | $362 |
| Pantoprazole Sodium Generic | 18 | 32 | Under 11 | $202 |
| Ofloxacin Generic | 18 | 18 | 14 | $785 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 18 | 18 | Under 11 | $314 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 17 | 17 | 15 | $229 |
| Hydrocortisone-Acetic Acid Hydrocortisone/Acetic Acid | 14 | 14 | 11 | $917 |
Brand drugs: 17 claims; generic drugs: 920 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Regala $463 ($463 in general payments such as food, travel and fees) from 5 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $209.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.